82 FR 59626 - Determination Concerning a Petition To Add a Class of Employees to the Special Exposure Cohort
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 82, Issue 240 (December 15, 2017)
Federal Register Volume 82, Issue 240 (December 15, 2017)
| Page Range | 59626-59626 | |
| FR Document | 2017-27039 |
[Federal Register Volume 82, Number 240 (Friday, December 15, 2017)] [Notices] [Page 59626] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-27039] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Determination Concerning a Petition To Add a Class of Employees to the Special Exposure Cohort AGENCY: National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: HHS gives notice of a determination concerning a petition to add a class of employees from the Carborundum Company, in Niagara Falls, New York, to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000 (EEOICPA). FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 1090 Tusculum Avenue, MS C-46, Cincinnati, OH 45226-1938, Telephone 1-877-222-7570. Information requests can also be submitted by email to [email protected]. SUPPLEMENTARY INFORMATION: Authority: [42 U.S.C.7384q]. On November 16, 2017, the Acting Secretary of HHS determined that the following class of employees does not meet the statutory criteria for addition to the SEC as authorized under EEOICPA: All employees who worked in any area of the Carborundum Company facility on Buffalo Avenue, Niagara Falls, New York, from January 1, 1943, through December 31, 1976. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2017-27039 Filed 12-14-17; 8:45 am] BILLING CODE 4163-19-P
![59626 Federal Register / Vol. 82, No. 240 / Friday, December 15, 2017 / Notices
or other forms of information DEPARTMENT OF HEALTH AND be recorded by knowingly requesting
technology to minimize the information HUMAN SERVICES biological testing of a mixture of
collection burden. compounds that he falsely claimed to
Office of the Secretary be a single compound
Amy McNulty, • In Manuscript 1, Respondent falsified
Acting Director, Division of the Executive Findings of Research Misconduct and/or fabricated the results on page
Secretariat. S26 of the Supporting Information by
AGENCY: Office of the Secretary, HHS.
[FR Doc. 2017–27013 Filed 12–14–17; 8:45 am] modifying the HPLC trace through
ACTION: Notice.
BILLING CODE 4165–15–P peak erasure to make the preparation
SUMMARY: Findings of research of C35deOAmB appear more pure
misconduct have been made on the part than in the actual results of
DEPARTMENT OF HEALTH AND of Matthew Endo, former graduate experimentation
HUMAN SERVICES student, Department of Chemistry, • In Manuscript 1, Respondent falsified
University of Illinois at Urbana- and/or fabricated the results of
Determination Concerning a Petition Champaign. The questioned research Surface Plasmon Resonance data on
To Add a Class of Employees to the was supported by National Institute of page S7 of the Supporting Information
Special Exposure Cohort General Medical Sciences (NIGMS), to make the error bars smaller than
National Institutes of Health (NIH), the actual results of experimentation
AGENCY: National Institute for grant R01 GM080436. The • In Manuscript 1, Respondent falsified
Occupational Safety and Health administrative actions, including three and/or fabricated the results of a
(NIOSH), Centers for Disease Control (3) years of supervision, which are WST08 Cell Proliferation Assay on
and Prevention, Department of Health implemented beginning on November page S32 of the Supporting
and Human Services (HHS). 16, 2017, are detailed below. Information by falsely claiming to run
FOR FURTHER INFORMATION CONTACT:
the reaction in triplicate when it was
ACTION: Notice. only performed in duplicate
Wanda K. Jones, Dr.P.H., Interim
Director, Office of Research Integrity, • In correspondence with his advisor,
SUMMARY: HHS gives notice of a Respondent falsified and/or fabricated
determination concerning a petition to 1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8200. the results of the preparation of
add a class of employees from the putative C2deoAmB where
Carborundum Company, in Niagara SUPPLEMENTARY INFORMATION: Notice is
Respondent modified and relabeled a
Falls, New York, to the Special hereby given that the Office of Research HPLC trace and relabeled an NMR
Exposure Cohort (SEC) under the Energy Integrity (ORI) has taken final action in spectrum to falsely claim
Employees Occupational Illness the following case: characterization, purity, and
Compensation Program Act of 2000 Matthew Endo, University of Illinois identification of sample that was sent
(EEOICPA). at Urbana-Champaign: Based on the for biological assay
Respondent’s admission, an assessment
conducted by University of Illinois at Mr. Endo entered into a Voluntary
FOR FURTHER INFORMATION CONTACT:
Urbana-Champaign (UIUC), and analysis Settlement Agreement and voluntarily
Stuart L. Hinnefeld, Director, Division agreed for a period of three (3) years,
of Compensation Analysis and Support, conducted by ORI in its oversight
review, ORI found that Mr. Matthew beginning on November 16, 2017:
National Institute for Occupational (1) To have his research supervised;
Safety and Health (NIOSH), 1090 Endo, a former graduate student,
Department of Chemistry, UIUC, Respondent agreed to ensure that prior
Tusculum Avenue, MS C–46, to the submission of an application for
Cincinnati, OH 45226–1938, Telephone engaged in research misconduct in
research supported by National Institute PHS support for a research project on
1–877–222–7570. Information requests which Respondent’s participation is
of General Medical Sciences (NIGMS),
can also be submitted by email to proposed and prior to Respondent’s
National Institutes of Health (NIH),
DCAS@CDC.GOV. participation in any capacity on PHS-
grant R01 GM080436.
SUPPLEMENTARY INFORMATION: ORI found that Respondent engaged supported research, the institution
in research misconduct by intentionally, employing him must submit a plan for
Authority: [42 U.S.C.7384q]. supervision of Respondent’s duties to
knowingly, or recklessly causing false
data to be recorded, falsifying and/or ORI for approval; the plan for
On November 16, 2017, the Acting
fabricating data and related images by supervision must be designed to ensure
Secretary of HHS determined that the the scientific integrity of Respondent’s
following class of employees does not alteration and/or reuse and/or relabeling
of experimental data, and reporting research contribution; Respondent
meet the statutory criteria for addition agreed that he will not participate in
to the SEC as authorized under falsified and/or fabricated data in one
(1) manuscript subsequently submitted any PHS-supported research until a plan
EEOICPA: for supervision is submitted and
for publication:
All employees who worked in any area of • ‘‘Amphotericin primarily kills human approved by ORI;
the Carborundum Company facility on cells by binding and extracting (2) that any institution employing him
Buffalo Avenue, Niagara Falls, New York, cholesterol.’’ Submitted for must submit in conjunction with each
from January 1, 1943, through December 31, publication to the Proceedings of the application for PHS funds, or report,
manuscript, or abstract involving PHS
sradovich on DSK3GMQ082PROD with NOTICES
1976. National Academy of Sciences
[withdrawn prior to peer review] supported research in which
John Howard, Respondent is involved, a certification
Director, National Institute for Occupational (hereafter referred to as ‘‘Manuscript
1’’) to ORI that the data provided by
Safety and Health. Respondent are based on actual
[FR Doc. 2017–27039 Filed 12–14–17; 8:45 am] Specifically, ORI found that: experiments or are otherwise
BILLING CODE 4163–19–P • In Manuscript 1, Respondent caused legitimately derived and that the data,
falsified and/or fabricated results to procedures, and methodology are
VerDate Sep<11>2014 23:42 Dec 14, 2017 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\15DEN1.SGM 15DEN1](https://thefederalregister.org/doc/82_FR_59866/page/1.svg)
Document Created: 2017-12-15 03:37:08
Document Modified: 2017-12-15 03:37:08
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Contact | Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 1090 Tusculum Avenue, MS C-46, Cincinnati, OH 45226-1938, Telephone 1-877-222-7570. Information requests can also be submitted by email to [email protected] | |
| FR Citation | 82 FR 59626 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR